Cladis Investment Advisory »

Ptc Therapeutics I shares owned by Cladis Investment Advisory

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Cladis Investment Advisory from 13F filings

Historical chart of Cladis Investment Advisory investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Cladis Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Cladis Investment Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $319k 5.2k 61.37
2025-06-30 $254k 5.2k 48.84
2025-03-31 $204k 4.0k 50.96

More positions owned by Cladis Investment Advisory

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ge Aerospace Com New (GE)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser Q (QQQ)
Eli Lilly & Co. (LLY)
International Business Machines (IBM)
Select Sector Spdr Tr Technology (XLK)
Ge Vernova (GEV)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
First Intst Bancsystem Com Cl A (FIBK)
At&t (T)
Exxon Mobil Corporation (XOM)
Costco Wholesale Corporation (COST)

View all positions for Cladis Investment Advisory

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I